3D Cell Culture Market

3D Cell Culture Market Size, Growth (2020 to 2025)

As per our report, the size of the global 3D cell culture market is estimated to worth USD 1.81 billion by 2025, growing at a CAGR of 14.8% during the forecast period.

3D Cell culture is a feigned generated environment in which biological cells are stored and allowed to grow within the surrounding environment. In general, 3D cell cultures are used for the research of the cell tissues for decades. The 3D process of cell culture has begun in the early 20^th century to enlarge the expansion of in-vitro tissue cultures. These procedures are being used for in-vitro diseases that are used for identifying cellular responses to the pharmaceutical composition. These 3D cell cultures have a long period of endurance.

This 3D cell culture is used for the study of the diseases, mainly to figure out the disease stage. Further, the applications expanded to areas such as regenerative medicine, tissue engineering, biomedical and clinical studies. The presence of 3D cell culture plays a vital role in in-vitro cell responses and also in stem cell, cancer cell and so on.

MARKET DRIVERS

The advantages of the 3D cell culture to avoid the flaws of 2D monolayer cultures is expected to drive market growth.

Growing adoption of 3D over 2D and the availability of enormous market potential are expected to lavish the 3D cell culture market in the coming years. Increasing technological advancements related to 3D cell culture to do better R & D of cell tissues is also providing a significant boost to the market growth. Since last few years, the focus to develop alternatives for animal testing is growing significantly, which is expected to provide growth opportunities to the global 3D cell culture market. 3D cell culture in examining the drugs and in the manufacturing of vaccines and biopharmaceuticals further accelerating the market growth.

MARKET RESTRAINTS

Lack of proper infrastructure, high costs associated with the R & D of 3D cell culture are the major factors limiting the market growth to some extent. Shortage of investments by the government bodies and other organizations is also expected to hamper the market growth to a limited extent. Lack of skilled clinicians and lab technicians in the industry of 3D cell culture is also showing a minor negative impact on the market.

REPORT COVERAGE:

This research report on the Global 3D Cell Culture Market segmented and sub-segmented based on the Product, Application, End-user and Region.

3D Cell Culture Market - By Product

• Scaffold-based 3D Cell Cultures
  • Hydrogels/ECM Analogs
  • Solid Scaffolds
  • Micropatterned Surfaces
• Scaffold-free 3D Cell Cultures
  • Low Attachment Plates
  • Hanging Drop Plates
  • 3D Bioreactors
  • 3D Petri Dishes
• Microfluidics-based 3D Cell Cultures       
• Magnetic & Bioprinted 3D Cell Cultures

Based on the Product, the scaffolding 3D cell culture segment was the dominating segment in the year 2019 and expected to showcase the highest CAGR in the forecast period. The steady growth of this segment is attributed to the ability of scaffolding products to mimic in vivo conditions, which favours their adoption by end-users.

3D Cell Culture Market - By Application

• Cancer & Stem Cell Research
• Drug Discovery & Toxicology Testing
• Tissue Engineering & Regenerative Medicine

Based on Application, the stem cell and cancer segment represented the largest market share in 2019. The growth of this segment of applications is attributed to the growing incidence of cancer and essential funding initiatives for cancer research by governmental and private organizations.

3D Cell Culture Market - By End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Cosmetics Industry
• Other End Users

3D Cell Culture Market - By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the global market is dominated by North America in 2019, followed by Europe, Asia-Pacific and the rest of the world. United States 3d cell culture market is leading the North American market, followed by Canada. Factors such as the increase in the incidence of cancer, the presence of well-established pharmaceutical and biotechnological industries and the availability of technologically advanced products are majorly driving the market growth in this region.

European 3d cell culture market is the second global leader in the market of 3D cell culture and dominated by counties like the United Kingdom, Spain, Italy, France and Germany. Recently growing demand for micro fluids commercialization and research is the foremost opportunity for the market and the continuous interest shown by the European countries in research on oncology diseases gives fuel to the market size. The rise in the number of patients who have cancer is levelling up the demand of the market. Also, increasing research on stem cell for regenerative medicines create a space for new market opportunities.

Asia Pacific 3d cell culture market region is expected to grow at the highest share during the forecast period. China and India are the major countries that are offering significant support for the 3D cell culture market in the Asia Pacific region. Besides, Japan and South Korea are also contributing well to expand the market size in this Region. The Asia Pacific 3D cell culture market is majorly driven due to the strong presence of various significant players of pharmaceutical and biotech industries in China and India. Rising demand for cancer-related drugs is market growth in this region. Also, increasing the Application of 3D cell culture for study and drug developments is enhancing the need of the market.

TOP COMPANIES IN THE MARKET

Some of the key market participants leading the Global 3D Cell Culture Market profiled in this report are MIMETAS, Hamilton Company, CN Bio, Advanced BioMatrix, Merck KGaA, REPROCELL Incorporated, Thermo Fisher Scientific, 3D Biotek, Lonza AG, Corning Incorporated, TissUse, PromoCell, InSphero and Synthecon.

RECENT MARKET DEVELOPMENTS

On January 23, 2020, Hystem line of products were acquired by Advanced BioMatrix from Lineage Cell Therapeutics. Hystem kits are built on new hyaluronic acid technology. This acquisition involves the shifting of applied sciences, intellectual property for the research and development purposes.

On April 05, 2019, MIMETAS announced about the launch of its new laboratory associated with the 3D microfluidic cell culture device OrganoPlate. The start of the new laboratory provides MIMETAS with new dimensions for growth. The OrganoPlate bear the 3D cell culture under steady intromission.

On March 21, 2017, Greiner Bio-One has united with Nano3D Biosciences to bring up a new perimeter in the biotechnology by acquiring the products from 3D cell culture. This collaboration works combined to oblige physical utilization of growing cell cultures that offer benefits to increase the exploratory outcomes.